• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从子宫内膜神经内分泌癌建立细胞系及侵袭模型。

Establishment of a cell line from a neuroendocrine carcinoma of the endometrium and an invasion model.

作者信息

Yoshida Y, Kamitani N, Sasaki H, Kotsuji F

机构信息

Department of Obstetrics and Gynecology, Fukui Medical University, Japan.

出版信息

Anticancer Res. 1998 May-Jun;18(3A):1569-77.

PMID:9673372
Abstract

A new cell line (YKK) was established from a primary tumor of neuroendocrine carcinoma of the endometrium. Cultured YKK cells are polygonal in shape. The modal chromosome number is 46 XX. The doubling time of the cells, after the 19th passage, is 38 hours and this cell line has been propagated continuously by serial passage over 50 passages for the past 2 years. YKK displays characteristics resembling the original tumor cell from the donor patient: it contains the neuron-specific enolase and chromogranin antibody, produces neuron-specific enolase, and is sensitive to cisplatin, carboplatin, and etoposide. When YKK cells are transplanted subcutaneously together with Matrigel into nude mice they form a very large tumor invading the subcutaneous muscular tissue. This experimental model is useful for studying the mechanism(s) regulating the invasion of this tumor into muscular tissue, and for the establishment of new anti-cancer treatments for neuroendocrine carcinoma.

摘要

一种新的细胞系(YKK)是从子宫内膜神经内分泌癌的原发性肿瘤中建立的。培养的YKK细胞呈多边形。众数染色体数为46 XX。第19代后细胞的倍增时间为38小时,在过去两年中,该细胞系已通过连续传代在50代以上持续传代培养。YKK表现出与供体患者原始肿瘤细胞相似的特征:它含有神经元特异性烯醇化酶和嗜铬粒蛋白抗体,产生神经元特异性烯醇化酶,并且对顺铂、卡铂和依托泊苷敏感。当YKK细胞与基质胶一起皮下移植到裸鼠体内时,它们会形成一个非常大的肿瘤,侵入皮下肌肉组织。该实验模型可用于研究调节该肿瘤侵入肌肉组织的机制,以及建立神经内分泌癌的新抗癌治疗方法。

相似文献

1
Establishment of a cell line from a neuroendocrine carcinoma of the endometrium and an invasion model.从子宫内膜神经内分泌癌建立细胞系及侵袭模型。
Anticancer Res. 1998 May-Jun;18(3A):1569-77.
2
Growth and characterization of a cell line from a human primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma) in culture and as xenograft.人原发性皮肤神经内分泌癌(默克尔细胞癌)细胞系在培养及异种移植中的生长与特性研究
J Cell Physiol. 2001 Jun;187(3):386-91. doi: 10.1002/jcp.1086.
3
[Establishment and characterization of the new cell line (EI) from a human endometrial adenocarcinoma].
Hum Cell. 1995 Mar;8(1):43-8.
4
Establishment and characterization of a renal cell carcinoma cell line (FU-UR-1) with the reciprocal ASPL-TFE3 fusion transcript.具有ASPL-TFE3相互融合转录本的肾癌细胞系(FU-UR-1)的建立与鉴定
Oncol Rep. 2004 Jun;11(6):1169-75.
5
Establishment of a prostatic small-cell carcinoma cell line (SO-MI).
Prostate. 2003 Aug 1;56(3):231-8. doi: 10.1002/pros.10253.
6
Establishment of a highly metastatic human ovarian cancer cell line (HO-8910PM) and its characterization.高转移人卵巢癌细胞系(HO-8910PM)的建立及其特性研究。
J Exp Clin Cancer Res. 1999 Jun;18(2):233-9.
7
Establishment and characterization of human pancreatic adenocarcinoma cell line in tissue culture and the nude mouse.人胰腺腺癌细胞系在组织培养及裸鼠中的建立与鉴定
Tissue Cell. 2007 Aug;39(4):217-23. doi: 10.1016/j.tice.2007.04.001. Epub 2007 Jun 8.
8
MaMi, a human endometrial stromal sarcoma cell line that constitutively produces interleukin-6, interleukin-8, and monocyte chemoattractant protein-1.MaMi是一种人子宫内膜间质肉瘤细胞系,可组成性产生白细胞介素-6、白细胞介素-8和单核细胞趋化蛋白-1。
Arch Pathol Lab Med. 1998 Sep;122(9):836-41.
9
[Studies of the origin of malignant rhabdoid tumor(MRT)--experimental researches on the MRT evolving in nude mice inoculated with violently variable HeLa cells].[恶性横纹肌样瘤(MRT)起源的研究——接种高度变异HeLa细胞的裸鼠体内MRT演变的实验研究]
Yi Chuan Xue Bao. 2000;27(12):1057-71.
10
New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.具有高转移潜能的新型人肝细胞癌(HCC)细胞系(MHCC97)及其转移相关因子的表达
Br J Cancer. 1999 Nov;81(5):814-21. doi: 10.1038/sj.bjc.6690769.